CARDIO-PAD
Présenté par Mr. Arthur ZANG
Tablette Médicale Pour Les Examens Cardiaques et le Diagnostic à distance
Fondateur et Directeur General de Himore Medical S.A
®
>> GENESIS OF THE PROBLEMTHE HEART
Pumps blood toother organs
MAIN HUMAN BODY ORGAN
CARDIOVASCULAR DISEASES
(CVD)
INT
RO
DU
CT
ION
>> THE PROBLEM
Globally 17.3 MILLION DEATHS/YEAR
30% TOTAL MORTALITY
CARDIOVASCULAR DISEASES
INT
RO
DU
CT
ION
CENTRAL AFRICA
1.2 Million deaths/year 22% Total Mortality
>> BACKGROUNDCENTRAL AFRICA
INT
RO
DU
CT
ION
Less than 40 CARDIOLOGISTS for
More Than 20 MILLIONS PEOPLE
CAMEROON
>> THE SITUATIONFACTORS & CONSEQUENCES
Total Patient Cost
Transport
Exams Cost
Housing
+
+
I I SOLUTION:
REMOTE MEDICAL EXAMINATIONS • Reduce CVD mortality• Improve public health
INT
RO
DU
CT
ION
Perform ECG examinations in district hospitals modest budget, located in rural areas, no specialist cardiologist
Reduce risks and costs for patients Limited time and money
Facilitate the work of cardiologists Remote interpretation and computer-assisted diagnosis ,mobility in the workplace, better monitoring of patients
Management of biomedical data Large Scale, treatment, and remote access of data
OBJECTIVES
SO
LU
TIO
N
SOLUTION LOCAL LEVEL GLOBAL LEVEL
>> THE SOLUTIONTHE CARDIO-PAD
HospitalRecordingCardiac exams withthe Cardio-pad, Medical touch tablet
Perform ECG examinations for patients
Transmit exams to remote cardiologists
Intuitive user interface to help cardiologists make their diagnosis
Functionalities
Information storage and management of ECG exam notifications
Remote monitoring of patients
>> CARDIOGLOBARCHITECTURE
SO
LU
TIO
N
Overall Success: 97.7%
Test File Duration ofSignal
Total Number of Heartbeats
Heartbeats detected
False positives Heartbeats undetected
Percentage of success
100 60 secondes 74 74 0 0 100%
101 60 secondes 71 71 0 0 100%
102 60 secondes 73 72 0 1 98.63%
105 60 secondes 83 83 0 0 100%
210 60 secondes 93 97 4 0 95.69%
GEN
ESIS
Prof. Samuel KinguéCardiologist, medical science department of yaoundé
Prof. Claude TanghaPolytechnic high school Yaoundé
Prof. Pierre Tricot Polytechnic school france
Arthur ZangCreator of Cardio-Pad
CARDIOPAD TESTING RESULTS 2009-2010
GEN
ESIS
MASTER THESIS: CARDIOGLOBDESIGN AND DEVELOPMENT OF SYSTEM FOR
ACQUISITION, PROCESSING AND TRANSMISSION USING GSM OF CARDIAC
SIGNAL.
Prof. Samuel Kingué et Prof. Claude Tangha
17.5 / 20
CARDIOPAD TESTING RESULTS 2010-2011
GEN
ESE
MASTER DEGREE IN SOFWARE DESIGN ENGINEERING
TWO SCIENTIFIC PUBLICATIONS
AWARDS AND RECOGNITION
GEN
ESE
MICROSOFTSEMI-FINALISTS AT IMAGINE CUP COMPETITION
ORANGE TELECOM4th Place at African Social Entrepreneur competition
FING ORGANISATION Presented at “Carrefour des Possibles”
CARDIO-PADInnovation and competition
FEBRUARY 2011
NOVEMBER 2011
DECEMBER 2011
PadECGExam
3,6,12 Pistes
Fonctionnalités
FONCTIONNALITES DU CARDIOPAD20 juin 2012 au 30/11/2012
3.B
>> EXECUTION DU CHRONOGRAMME
PadECGScope ECGAnalyse
PADTRANSMIT
Transfert des données
Acquisition Processing Transmition X Storage Remote monitoring X Remote diagnostic X Mobility X Average Price $5 000 $2600
>>ADVANTAGES OF THE SOLUTION
SOLU
TION
CONVENTIONAL ECG DEVICES CARDIO-PAD
OURS CUSTOMERSBIG Hospitalscentral and general Hospitals
LABORATORIESPerforming examsregardless ofinterpretations
District HospitalsSmall rural hospital without cardiologist services
80 %
TARGET CUSTOMERS
STATUS OF THE PROJECTPrototype 2011
MANUFACTURINGFirst Tablet
MEDICAL DEVICES MANUFACTURING COMPANY
Himore Medical founded in 2012 in order to manufacture, commercialise
and bring to market the CARDIOGLOB solution.
COMPANY BACKGROUND
Grant Funded with $25,000 usd by the government of Cameroon
7 Employees
Private Investment of $5,000
Headquatered in Yaoundé, Cameroon associated with the
University of Yaoundé
One Issued Patent
Under Contract with Public Health Minister of Cameroon for
initial implementation of Cardioglob
THE TEAM
HIMORE MEDICAL : • 3 Software Engineers• 1 Biomedical Engineer• 2 Cardiologists• 1 Mathematician
STRATEGIC PARTNERS : Microsoft, Embest, Quickembedd
30 Finished Products from first Manufacturing round
FACEBOOKYOUTUBESOCIAL MEDIA MARKETING
>> CARDIOPAD IN THE NEWS
REVENUE MODEL2012-2013 2013-2014 2014-2015
Examination fee $20 $20 $20
x x x
Min. Exam/Machine
8 7 5
x x x
Total No. of Machine
30 60 100
x x x
No. working days 300 292 288
TOTAL. Annual $1,440,000 $2,452,000 $2,880,000
PROFIT DISTRIBUTION
2012-2013 2013-2014 2014-20150
500,000
1,000,000
1,500,000
2,000,000
2,500,000
3,000,000
3,500,000
$259,200 $441,360 $518,400
$720,000
$1,226,000$1,440,000$460,800
$784,640
$921,600
Cardiologist 18% Himore Medical 50%Hospital 32%
Capital need
• Himore Medical seeks $500,000 in additional investment to support further growth.
• Capital will be deployed as follows:• $300,000 to support manufacturing and
distribution of the Cardiopad• $200,000 to support development of future
products and generation of additional IP
Compelling investment highlights
• Strong Patent protection
• Attractive Market opportunity and unmet need
• Positive Social Impact
• Scalable Technology
• Innovative technology built on proven and secure platform that reduces the investment risks.
Contact• Site : facebook.com/cardiopad• Email : marc_arthur [email protected]• Tél : (+237) 94 42 61 25
LES MEMBRES DU PROJET• ING. Arthur ZANG• Prof. Samuel KINGUE• ING. JEAN CEDRIC EVINA ONDOA• ING. JEAN PIERRE ANGUISSA ABESSOLO
CARDIO-PAD IN HOSPITAL